Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004735 · ClinicalTrials.gov registry record · NA
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT00004735 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 81 participants.
The verdict
NCT00004735, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the number of newly formed CD4 cells in children who have taken anti-HIV drugs. The study will also evaluate the effectiveness of the new CD4 cells in producing an immune response to hepatitis A and tetanus toxoid vaccination. Study hypothesis: 1) Immunologic reconstitution of individuals who have less than 15% CD4 cells may or may not be associated with functional activity. 2) The functional immunologic responses to recall and newly experienced antigens may be different. 3) The functional responses to antigens delivered in vaccine format may be a function of CD4 level, viral load, or both.
Interventions
- BIOLOGICAL Hepatitis A Vaccine (Inactivated)
- BIOLOGICAL Tetanus toxoid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2000-02 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004735
The ClinicalTrials.gov registry entry for NCT00004735 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hepatitis A Vaccine (Inactivated) is the first listed.
NCT00004735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004735 about?
NCT00004735 is a clinical study titled "The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV". The purpose of this study is to determine the number of newly formed CD4 cells in children who have taken anti-HIV drugs. The study will also evaluate the effectiveness of the new CD4 cells in producing an immune response to hepatitis A and tetanus toxoid vaccination. Study hypothesis: 1) Immunolog...
What is the current status of trial NCT00004735?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2000-02. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00004735?
The interventions under investigation include: Hepatitis A Vaccine (Inactivated) (BIOLOGICAL), Tetanus toxoid (BIOLOGICAL).
Who is sponsoring clinical trial NCT00004735?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.